• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bone scan in initial staging of prostate cancer.

作者信息

Boughattas Sami, Letaief Bechir, Hassine Habib, Chatti Kaouther, Essabah Habib

机构信息

Service de Médecine Nucléaire, Hopital Sahloul, Sousse, Tunisie.

出版信息

Tunis Med. 2003 Jun;81(6):400-6.

PMID:14534946
Abstract

Bone scans of 64 patients with newly diagnosed prostate cancer were retrospectively analysed. Metastases were present in 29 patients (45%). In 75% of these cases, the pattern was manifeastly metastatic. The third threshold has high negative and positive predictive values. The topography of metastatic lesions is in favour of a systemic spread. There were no metastatic cases with a PSA level under 10 ng/ml. Multiple IAU and intense IAU are the most specific patterns of metastatic lesions. Also, focal lesions on sacroiliacs are also in favour of metastatic origin. The distribution of metastases is globally similar to that of the bone marrow in adult and systemic spread is the most probable. Staging bone scan must be reserved to patients with PSA level greater than 10 ng/ml, poorly degree of differentiation and advanced clinical stage.

摘要

相似文献

1
Bone scan in initial staging of prostate cancer.
Tunis Med. 2003 Jun;81(6):400-6.
2
[Is it possible to do without bone gammagraphy in the staging of prostatic cancer?].[前列腺癌分期中不进行骨闪烁造影是否可行?]
Actas Urol Esp. 1995 Feb;19(2):123-7.
3
Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.血清前列腺特异性抗原水平预测新诊断前列腺癌患者骨扫描结果正常的能力。
Urology. 1996 May;47(5):708-12. doi: 10.1016/s0090-4295(96)80016-1.
4
Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.在诊断初期,对于 PSA 水平 <=20ng/ml 且 Gleason 评分为 <=6 的无症状前列腺癌患者,可以免除骨扫描。
Jpn J Clin Oncol. 2011 Oct;41(10):1209-13. doi: 10.1093/jjco/hyr118. Epub 2011 Aug 23.
5
Which patients with prostatic carcinoma require a staging bone scan?
Br J Urol. 1997 Apr;79(4):611-4. doi: 10.1046/j.1464-410x.1997.00121.x.
6
Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.前列腺特异性抗原作为前列腺癌患者骨转移的标志物。
Urol Int. 1996;56(3):169-73. doi: 10.1159/000282834.
7
Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.用于预测日本前列腺癌患者是否需要进行放射性核素骨扫描的前列腺特异性抗原、Gleason评分总和及临床T分期
Int J Urol. 2005 Aug;12(8):728-32. doi: 10.1111/j.1442-2042.2005.01118.x.
8
Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.初次前列腺特异性抗原检测能否消除新诊断前列腺癌患者进行骨扫描的必要性?一项在日本开展的多中心回顾性研究。
Cancer. 2002 Feb 15;94(4):964-72.
9
Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?前列腺特异性抗原水平能否预测新诊断前列腺癌患者骨扫描转移证据?
Am J Clin Oncol. 1994 Oct;17(5):432-6. doi: 10.1097/00000421-199410000-00016.
10
Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.应用 sPSA 预测初诊前列腺癌患者骨扫描结果:在亚洲人群中的可行性。
Urol Oncol. 2011 May-Jun;29(3):275-9. doi: 10.1016/j.urolonc.2009.05.007. Epub 2009 Sep 6.